Veterinary Medicines

KOLIBIN RC NEO, injekcinė emulsija galvijams

Authorised
  • Bovine rotavirus, strain TM-91, Inactivated
  • Bovine coronavirus, strain C-197, Inactivated
  • Escherichia coli, serotype O8:K35 (fimbrial adhesin F5), Inactivated
  • Escherichia coli, serotype O9:K35, Inactivated
  • Escherichia coli, serotype O101:K30 (fimbrial adhesin F5), Inactivated
Download as PDF

Product identification

Medicine name:
KOLIBIN RC NEO, injekcinė emulsija galvijams
Active substance:
  • Bovine rotavirus, strain TM-91, Inactivated
  • Bovine coronavirus, strain C-197, Inactivated
  • Escherichia coli, serotype O8:K35 (fimbrial adhesin F5), Inactivated
  • Escherichia coli, serotype O9:K35, Inactivated
  • Escherichia coli, serotype O101:K30 (fimbrial adhesin F5), Inactivated
Target species:
  • Cattle (heifer)
  • Cattle (pregnant cow)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Bovine rotavirus, strain TM-91, Inactivated
    1.00
    relative potency
    /
    2.00
    millilitre(s)
  • Bovine coronavirus, strain C-197, Inactivated
    1.00
    relative potency
    /
    2.00
    millilitre(s)
  • Escherichia coli, serotype O8:K35 (fimbrial adhesin F5), Inactivated
    1.00
    relative potency
    /
    2.00
    millilitre(s)
  • Escherichia coli, serotype O9:K35, Inactivated
    1.00
    relative potency
    /
    2.00
    millilitre(s)
  • Escherichia coli, serotype O101:K30 (fimbrial adhesin F5), Inactivated
    1.00
    relative potency
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle (heifer)
    • Cattle (pregnant cow)
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetmarket UAB
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/21/2692/001-004
Date of authorisation status change:

Documents

RV2692.pdf

Lithuanian (PDF)
Published on: 14/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."